Search results
Promising melanoma therapy could be the next major advancement in cancer treatment
NBC News via Yahoo News· 2 years agoAn experimental treatment for advanced melanoma is poised to be the next major advance in cancer...
Instil (TIL) Stock Rises More Than 20% in a Week: Here's Why
Zacks via Yahoo Finance· 5 months agoShares of Instil Bio, Inc. TIL have rallied 22.2% in the past week against the industry’s decrease...
APAC leaps ahead in adoptive cell therapy space
Pharmaceutical Technology via Yahoo Finance· 11 hours agoThe Asia Pacific (APAC) region is leading the charge for adoptive cell therapy studies, says Scotty Chung-Siu, a managing analyst at GlobalData. At the...
Test may identify which breast cancer patients can safely skip chemo
United Press International via Yahoo News· 2 months agoWomen with early-stage triple-negative breast cancer appear to have better survival rates and a...
New cell-based therapy for melanoma more effective than existing treatment, trial finds
NBC News via Yahoo News· 2 years agoEuropean researchers announced Saturday that a new treatment for advanced melanoma was more...
Is Iovance a Buy After Its First Regulatory Win?
Motley Fool via Yahoo Finance· 4 months agoIovance Biotherapeutics (NASDAQ: IOVA) just reached a huge milestone -- and investors have flocked to the stock, helping it to soar more than 70% in less...
Iovance, with approval of ‘TIL’ cell therapy, readies for complex launch
BioPharma Dive via Yahoo Finance· 4 months agoThe biotech set a price of roughly $515,000 per patient for its therapy Amtagvi, the first to be...
Is Iovance Biotherapeutics Stock a Buy Now?
Motley Fool via Yahoo Finance· 4 months agoAs with most pre-revenue biotech companies, Iovance Biotherapeutics (NASDAQ: IOVA) has a lot to prove. With its cash reserves running low and its first...
Why Iovance Stock Is Down 18% Today
Motley Fool via Yahoo Finance· 1 month agoIovance Biotherapeutics (NASDAQ: IOVA) shares are down to the tune of 18% today following Thursday evening's release of its first-quarter numbers. The...
Is Iovance Biotherapeutics a Buy Before This Key FDA Decision?
Motley Fool via Yahoo Finance· 4 months agoIovance Biotherapeutics (NASDAQ: IOVA) has reached a major turning point in its story as a company....
